Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crossover trial of oral transmucosal fentanyl citrate for exertional dyspnea in advanced cancer
2010-021399-26Phase 2Completed
- Sponsor
- Fundesalud
- Start
- Nov 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of fentanyl (2 arms), sponsored by Fundesalud. Primary endpoint: Change in exertional dyspnea (ESAS dyspnea VAS). Started Nov 2010; status: completed.
02
Drugs
fentanyl
Beyond the preview
Go deeper on 2010-021399-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021399-26.